These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28557747)

  • 1. Supplemental Iodide for Preterm Infants and Developmental Outcomes at 2 Years: An RCT.
    Williams FLR; Ogston S; Hume R; Watson J; Stanbury K; Willatts P; Boelen A; Juszczak E; Brocklehurst P;
    Pediatrics; 2017 May; 139(5):. PubMed ID: 28557747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurodevelopmental Outcomes at 42 Months After Thyroxine Supplementation in Infants Below 28 Weeks' Gestation: A Randomized Controlled Trial.
    Ng SM; Turner MA; Weindling AM
    Thyroid; 2020 Jul; 30(7):948-954. PubMed ID: 32070246
    [No Abstract]   [Full Text] [Related]  

  • 3. Iodine supplementation for the prevention of mortality and adverse neurodevelopmental outcomes in preterm infants.
    Walsh V; Brown JVE; McGuire W
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD005253. PubMed ID: 30802939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid function in preterm infants and neurodevelopment at 2 years.
    Williams FLR; Lindgren A; Watson J; Boelen A; Cheetham T
    Arch Dis Child Fetal Neonatal Ed; 2020 Sep; 105(5):504-509. PubMed ID: 32079615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iodine supplementation for the prevention of mortality and adverse neurodevelopmental outcomes in preterm infants.
    Ibrahim M; Sinn J; McGuire W
    Cochrane Database Syst Rev; 2006 Apr; (2):CD005253. PubMed ID: 16625632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mild maternal thyroid dysfunction at delivery of infants born ≤34 weeks and neurodevelopmental outcome at 5.5 years.
    Williams F; Watson J; Ogston S; Hume R; Willatts P; Visser T;
    J Clin Endocrinol Metab; 2012 Jun; 97(6):1977-85. PubMed ID: 22492778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodevelopmental outcome of nutritional intervention in newborn infants at risk of neurodevelopmental impairment: the Dolphin neonatal double-blind randomized controlled trial.
    Andrew MJ; Parr JR; Montague-Johnson C; Laler K; Holmes J; Baker B; Sullivan PB
    Dev Med Child Neurol; 2018 Sep; 60(9):897-905. PubMed ID: 29806081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Docosahexaenoic Acid Supplementation vs Placebo on Developmental Outcomes of Toddlers Born Preterm: A Randomized Clinical Trial.
    Keim SA; Boone KM; Klebanoff MA; Turner AN; Rausch J; Nelin MA; Rogers LK; Yeates KO; Nelin L; Sheppard KW
    JAMA Pediatr; 2018 Dec; 172(12):1126-1134. PubMed ID: 30357263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid function in very preterm newborns: possible implications.
    Van Wassenaer AG; Kok JH; Briët JM; Pijning AM; de Vijlder JJ
    Thyroid; 1999 Jan; 9(1):85-91. PubMed ID: 10037082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enteral iron supplementation in preterm and low birth weight infants.
    Mills RJ; Davies MW
    Cochrane Database Syst Rev; 2012 Mar; (3):CD005095. PubMed ID: 22419305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal thyroxine supplementation in very preterm children: developmental outcome evaluated at early school age.
    Briët JM; van Wassenaer AG; Dekker FW; de Vijlder JJ; van Baar A; Kok JH
    Pediatrics; 2001 Apr; 107(4):712-8. PubMed ID: 11335749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten-year follow-up of children born at <30 weeks' gestational age supplemented with thyroxine in the neonatal period in a randomized, controlled trial.
    van Wassenaer AG; Westera J; Houtzager BA; Kok JH
    Pediatrics; 2005 Nov; 116(5):e613-8. PubMed ID: 16234230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Moderate and Late Preterm Birth and Neurodevelopment and Social-Emotional Development at Age 2 Years.
    Cheong JL; Doyle LW; Burnett AC; Lee KJ; Walsh JM; Potter CR; Treyvaud K; Thompson DK; Olsen JE; Anderson PJ; Spittle AJ
    JAMA Pediatr; 2017 Apr; 171(4):e164805. PubMed ID: 28152144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is intravenous fish oil associated with the neurodevelopment of extremely low birth weight preterm infants on parenteral nutrition?
    Biagetti C; Correani A; D'Ascenzo R; Ferretti E; Proietti C; Antognoli L; Giretti I; Pompilio A; Cogo P; Carnielli VP
    Clin Nutr; 2021 May; 40(5):2845-2850. PubMed ID: 33933751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation.
    van Wassenaer AG; Kok JH; de Vijlder JJ; Briët JM; Smit BJ; Tamminga P; van Baar A; Dekker FW; Vulsma T
    N Engl J Med; 1997 Jan; 336(1):21-6. PubMed ID: 8970936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Early Prophylactic High-Dose Recombinant Human Erythropoietin in Very Preterm Infants on Neurodevelopmental Outcome at 2 Years: A Randomized Clinical Trial.
    Natalucci G; Latal B; Koller B; Rüegger C; Sick B; Held L; Bucher HU; Fauchère JC;
    JAMA; 2016 May; 315(19):2079-85. PubMed ID: 27187300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oral iodine supplementation in very low birth weight preterm infants for the prevention of thyroid function alterations during the neonatal period: results of a randomised assessor-blinded pilot trial and neurodevelopmental outcomes at 24 months.
    Ares S; Saenz-Rico B; Arnaez J; Diez-Sebastian J; Omeñaca F; Bernal J
    Eur J Pediatr; 2022 Mar; 181(3):959-972. PubMed ID: 34651206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo-controlled trial.
    Zhou SJ; Skeaff SA; Ryan P; Doyle LW; Anderson PJ; Kornman L; Mcphee AJ; Yelland LN; Makrides M
    Trials; 2015 Dec; 16():563. PubMed ID: 26654905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal High-Dose DHA Supplementation and Neurodevelopment at 18-22 Months of Preterm Children.
    Guillot M; Synnes A; Pronovost E; Qureshi M; Daboval T; Caouette G; Olivier F; Bartholomew J; Mohamed I; Massé E; Afifi J; Hendson L; Lemyre B; Luu TM; Strueby L; Cieslak Z; Yusuf K; Pelligra G; Ducruet T; Ndiaye ABKT; Angoa G; Sériès T; Piedboeuf B; Nuyt AM; Fraser W; Mâsse B; Lacaze-Masmonteil T; Lavoie PM; Marc I
    Pediatrics; 2022 Jul; 150(1):. PubMed ID: 35652296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodevelopmental outcomes of preterm infants conceived by assisted reproductive technology.
    Roychoudhury S; Lodha A; Synnes A; Abou Mehrem A; Canning R; Banihani R; Beltempo M; Theriault K; Yang J; Shah PS; Soraisham AS; ; ;
    Am J Obstet Gynecol; 2021 Sep; 225(3):276.e1-276.e9. PubMed ID: 33798481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.